<DOC>
	<DOCNO>NCT02460588</DOCNO>
	<brief_summary>Acute exacerbation idiopathic pulmonary fibrosis ( AE-IPF ) major event IPF annual incidence 5 10 % responsible death one third IPF patient . When AE-IPF occurs , associate poor survival overall mortality 3 month upper 50 % . To date , treatment prove effective AE-IPF efficacy cyclophosphamide ( CYC ) survival suggest , mainly retrospective series need confirm . This confirmation mandatory improve prognosis AE-IPF also avoid unsuspected deleterious effect show immunosuppressor stable IPF .</brief_summary>
	<brief_title>Cyclophosphamide Acute Exacerbation Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description>Acute exacerbation idiopathic pulmonary fibrosis ( AE-IPF ) major event IPF annual incidence 5 10 % responsible death one third IPF patient . When AE-IPF occurs , associate poor survival overall mortality 3 month upper 50 % . To date , treatment prove effective AE-IPF efficacy CYC survival suggest , mainly retrospective series need confirm . This confirmation mandatory improve prognosis AE-IPF also avoid unsuspected deleterious effect show immunosuppressor stable IPF .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>Inclusion Criteria : â‰¥18 year age Definite probable IPF diagnosis define 2011 international recommendation Definite suspicion AE define IPFnet criterion exclusion alternative diagnosis acute worsen . Efficient contraceptive method within 1 month woman 3 month men last dose treatment Affiliation social security Able understand sign write informed consent form Identified etiology acute worsening ( i.e . infectious disease ) Known hypersensitivity contraindication CYC component study treatment Patient mechanical ventilation Active bacterial , viral , fungal parasitic infection Active cancer Patient lung transplantation wait list Treatment CYC last 12 month Patient participate another clinical trial Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>